HCA
CL icon

Horan Capital Advisors’s Colgate-Palmolive CL Stock Holding History

Horan Capital Advisors’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-432
Closed -$33K – 122
2020
Q3 		$33K Buy
+432
New +$32.9K 0.02% 195
2020
Q1 		– Sell
-432
Closed -$30K – 109
2019
Q4 		$30K Hold
432
– – 0.02% 172
2019
Q3 		$32K Buy
+432
New +$31.3K 0.02% 173
2019
Q2 		– Sell
-298
Closed -$20K – 103
2019
Q1 		$20K Buy
+298
New +$19.2K 0.01% 190
2017
Q4 		– Sell
-298
Closed -$22K – 107
2017
Q3 		$22K Buy
+298
New +$21.5K 0.01% 210

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Horan Capital Advisors's CL Position: Q4 2020 in Review

Horan Capital Advisors sold out of Colgate-Palmolive (CL) in Q4 2020, closing a stake of 432 shares — an estimated $33K sold.

Horan Capital Advisors first reported a position in CL in Q3 2017 and held it in 5 quarters. The position peaked at $33K in Q3 2020. 1,650 funds tracked by Wall St. Rank hold CL as of Q4 2020.

  • Horan Capital Advisors reported no remaining Colgate-Palmolive position as of Q4 2020 after selling out during the quarter.
  • Horan Capital Advisors sold 432 Colgate-Palmolive shares in Q4 2020, an estimated $33K.
  • Horan Capital Advisors first reported a position in Colgate-Palmolive in Q3 2017 and held it in 5 quarters.
  • Horan Capital Advisors's Colgate-Palmolive position peaked at $33K in Q3 2020.
  • 1,650 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2020.

Based on Horan Capital Advisors's 13F filing for Q4 2020, filed 2 Feb 2021.